Expression of human endogenous retrovirus clone 4-1 may correlate with blood plasma concentration of anti-U1 RNP and anti-Sm nuclear antibodies
Tóm tắt
The transcription of human endogenous retrovirus E (HERV-E) clone 4-1 was determined in peripheral blood mononuclear cells (PBMC) of patients with systemic lupus erythematosus (SLE). However, the contribution of HERV-E clone 4-1 expression in the development of SLE remains unclear. Blood plasma and PBMC from 55 patients with SLE and a control group of 35 healthy individuals were collected. Blood plasma concentration of five antinuclear antibodies including anti-U1 ribonucleoprotein (RNP), anti-Sm, anti-Scl-70, anti-single-stranded DNA (ssDNA), and anti-double-stranded DNA (dsDNA) was analyzed by enzyme-linked immunosorbent assay (ELISA). Total RNA was isolated from PBMC and reverse transcribed into cDNA. The number of copies of HERV-E clone 4-1 gag transcript in PBMC was determined by real-time quantitative polymerase chain reaction (RQ-PCR) analysis. Spearman statistical analysis indicated that blood plasma concentrations of anti-U1 RNP and anti-Sm antibodies may correlate with PBMC transcript levels of HERV-E clone 4-1 gag sequence (R=0.775, p<0.000001; R=0.698, p<0.000001, respectively). Our observations suggest that the expression of HERV-E clone 4-1 might be associated with production of anti-U1 RNP and anti-Sm antibodies in patients with SLE.
Tài liệu tham khảo
Sekigawa I, Naito T, Hira K et al (2004) Possible mechanisms of gender bias in SLE: a new hypothesis involving a comparison of SLE with atopy. Lupus 13:217–222
Stohl W, Metyas S, Tan SM, Cheema GS et al (2003) B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations. Arthritis Rheum 48:3475–3486
Quigg RJ (2004) Complement and autoimmune glomerular diseases. Curr Dir Autoimmun 7:165–180
Pirner K, Rascu A, Nurnberg W et al (1994) Evidence for direct anti-heparin-sulphate reactivity in sera of SLE patients. Rheumatol Int 14:169–174
Nakajima M, Nakajima A, Kayagaki N et al (1997) Expression of Fas ligand and its receptor in cutaneous lupus: implication in tissue injury. Clin Immunol Immunopathol 83:223–229
Rosen A, Casciola-Rosen L, Ahearn J (1995) Novel packages of viral and self-antigens are generated during apoptosis. J Exp Med 181:1557–1561
Zeng FQ, Yin RF, Tan GZ et al (2004) Characterization of DNA antigens from immune complexes deposited in the skin of patients with systemic lupus erythematosus. Chin Med J 117:1066–1071
Fillit H, Shibata S, Sasaki T et al (1993) Autoantibodies to the protein core of vascular basement membrane heparan sulfate proteoglycan in systemic lupus erythematosus. Autoimmunity 14:243–249
Greidinger EL, Foecking MF, Schafermeyer KR et al (2002) T cell immunity in connective tissue disease patients targets the RNA binding domain of the U1-70 kDa small nuclear ribonucleoprotein. J Immunol 169:3429–3437
Hishikawa T, Ogasawara H, Kaneko H et al (1997) Detection of antibodies to a recombinant gag protein derived from human endogenous retrovirus clone 4-1 in autoimmune diseases. Viral Immunol 10:137–147
Leib-Mosch C, Brack-Werner R, Werner T et al (1990) Endogenous retroviral elements in human DNA. Cancer Res 50:5636–5642
Talal N, Garry RF, Schur PH et al (1990) A conserved idiotype and antibodies to retroviral proteins in systemic lupus erythematosus. J Clin Invest 85:1866–1871
Ogasawara H, Naito T, Kaneko H et al (2001) Quantitative analyses of messenger RNA of human endogenous retrovirus in patients with systemic lupus erythematosus. J Rheumatol 28:533–538
Urnovitz HB, Murphy WH et al (1996) Human endogenous retroviruses: nature, occurrence, and clinical implications in human disease. Clin Microbiol Rev 9:72–99
Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277
Bombardier C, Gladman DD, Urowitz MB et al (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630–640
Weller TH, Coons AH et al (1954) Fluorescent antibody studies with agents of varicella and herpes zoster propagated in vitro. Proc Soc Exp Biol Med 86:789–794
Koshino K, Tokano Y, Hishikawa T et al (1995) Detection of antibodies to HIV-1 gp41 and HLA class II antigen-derived peptides in SLE patients. Scand J Rheumatol 24:288–292
Zack JA, Arrigo SJ, Weitsman SR et al (1990) HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 20:213–222
Naito T, Ogasawara H, Kaneko H et al (2003) Immune abnormalities induced by human endogenous retroviral peptides: with reference to the pathogenesis of systemic lupus erythematosus. J Clin Immunol 23:371–376
Douvas A, Takehana Y et al (1994) Cross-reactivity between autoimmune anti-U1 snRNP antibodies and neutralizing epitopes of HIV-1 gp120/41. AIDS Res Hum Retroviruses 10:253–262
Haustein UF, Pustowoit B, Krusche U et al (1993) Antibodies to retrovirus proteins in scleroderma. Acta Derm Venereol 73:116–118
Hishikawa T, Ogasawara H, Kaneko H et al (1997) Detection of antibodies to a recombinant gag protein derived from human endogenous retrovirus clone 4-1 in autoimmune diseases. Viral Immunol 10:137–147
Perl A (2001) Endogenous retroviruses in pathogenesis of autoimmunity. J Rheumatol 28:461–464
Bessis D, Moles JP, Basset-Seguin N et al (2004) Differential expression of a human endogenous retrovirus E transmembrane envelope glycoprotein in normal, psoriatic and atopic dermatitis human skin. Br J Dermatol 151:737–745
Villesen P, Aagaard L, Wiuf C et al (2004) Identification of endogenous retroviral reading frames in the human genome. Retrovirology 1:32–45